Literature DB >> 24182678

Effect of age and sex differences on wild-type transthyretin amyloid formation in familial amyloidotic polyneuropathy: a proteomic approach.

Masayoshi Tasaki1, Mitsuharu Ueda, Konen Obayashi, Haruki Koike, Keisuke Kitagawa, Yasuhiro Ogi, Hirofumi Jono, Yu Su, Genki Suenaga, Toshinori Oshima, Yohei Misumi, Mari Yoshida, Taro Yamashita, Gen Sobue, Yukio Ando.   

Abstract

BACKGROUND: Age and sex differences are closely related to the onset of senile systemic amyloidosis (SSA) caused by wild-type (WT) transthyretin (TTR). However, the effects of these differences on the amyloid formation mechanism in familial amyloid polyneuropathy (FAP) caused by variant TTR, have remained unclear. To elucidate age and sex differences in FAP, we investigated biochemical characteristics of amyloid deposits in different tissue sites of FAP by proteomic analysis.
METHODS: We used shotgun liquid chromatography/tandem mass spectrometry to analyze the proportions of variant and WT TTR in amyloid deposits in different tissues, such as cardiac, kidney, peripheral nerves, and gastrointestinal tissues, from 23 autopsied FAP cases. RESULTS AND
CONCLUSIONS: The analysis revealed a highly significant correlation between the proportion of WT TTR and age at autopsy in cardiac tissues, whereas the analysis indicated no correlation in kidney, peripheral nerves, and gastrointestinal tissues. In addition, we demonstrated age-related significantly increased WT TTR deposits, but not variant TTR deposits, in cardiac tissues of male patients. Taken together, these data suggest that both age and sex differences affect cardiac amyloid formation, mainly derived from WT TTR, in FAP.
© 2013.

Entities:  

Keywords:  Aging; Amyloidosis; Familial amyloidotic polyneuropathy; Proteome; Sex differences; Transthyretin

Mesh:

Substances:

Year:  2013        PMID: 24182678     DOI: 10.1016/j.ijcard.2013.10.033

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  10 in total

1.  Age-dependent cognitive dysfunction in untreated hereditary transthyretin amyloidosis.

Authors:  Ana Martins da Silva; Sara Cavaco; Joana Fernandes; Raquel Samões; Cristina Alves; Márcio Cardoso; Jeffery W Kelly; Cecília Monteiro; Teresa Coelho
Journal:  J Neurol       Date:  2017-12-05       Impact factor: 4.849

2.  Long-term treatment of transthyretin familial amyloid polyneuropathy with tafamidis: a clinical and neurophysiological study.

Authors:  Violaine Planté-Bordeneuve; Farida Gorram; Hayet Salhi; Tarik Nordine; Samar S Ayache; Philippe Le Corvoisier; Daniel Azoulay; Cyrille Feray; Thibaud Damy; Jean-Pascal Lefaucheur
Journal:  J Neurol       Date:  2016-11-22       Impact factor: 4.849

Review 3.  Newer Therapies for Amyloid Cardiomyopathy.

Authors:  Rajshekhar Chakraborty; Eli Muchtar; Morie A Gertz
Journal:  Curr Heart Fail Rep       Date:  2016-10

4.  The Clinical Impact of Proteomics in Amyloid Typing.

Authors:  Michelle M Hill; Surendra Dasari; Peter Mollee; Giampaolo Merlini; Catherine E Costello; Bouke P C Hazenberg; Martha Grogan; Angela Dispenzieri; Morie A Gertz; Taxiarchis Kourelis; Ellen D McPhail
Journal:  Mayo Clin Proc       Date:  2021-04-09       Impact factor: 11.104

Review 5.  Transthyretin cardiac amyloidosis: pathogenesis, treatments, and emerging role in heart failure with preserved ejection fraction.

Authors:  Van-Khue Ton; Monica Mukherjee; Daniel P Judge
Journal:  Clin Med Insights Cardiol       Date:  2015-01-05

6.  Abdominal fat pad biopsies exhibit good diagnostic accuracy in patients with suspected transthyretin amyloidosis.

Authors:  Hedvig Paulsson Rokke; Nima Sadat Gousheh; Per Westermark; Ole B Suhr; Intissar Anan; Elisabet Ihse; Björn Pilebro; Jonas Wixner
Journal:  Orphanet J Rare Dis       Date:  2020-10-08       Impact factor: 4.123

7.  Multi-omic analyses in Abyssinian cats with primary renal amyloid deposits.

Authors:  Francesca Genova; Simona Nonnis; Elisa Maffioli; Gabriella Tedeschi; Maria Giuseppina Strillacci; Michela Carisetti; Giuseppe Sironi; Francesca Anna Cupaioli; Noemi Di Nanni; Alessandra Mezzelani; Ettore Mosca; Christopher R Helps; Peter A J Leegwater; Laetitia Dorso; Maria Longeri
Journal:  Sci Rep       Date:  2021-04-16       Impact factor: 4.379

8.  Amyloid Cardiomyopathy in Hereditary Transthyretin V30M Amyloidosis - Impact of Sex and Amyloid Fibril Composition.

Authors:  Sandra Arvidsson; Björn Pilebro; Per Westermark; Per Lindqvist; Ole B Suhr
Journal:  PLoS One       Date:  2015-11-23       Impact factor: 3.240

Review 9.  Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm.

Authors:  Yoshiki Sekijima; Mitsuharu Ueda; Haruki Koike; Sonoko Misawa; Tomonori Ishii; Yukio Ando
Journal:  Orphanet J Rare Dis       Date:  2018-01-17       Impact factor: 4.123

10.  Transthyretin amyloid cardiomyopathy in women: frequency, characteristics, and diagnostic challenges.

Authors:  Marianna Bruno; Adam Castaño; Arianna Burton; Justin L Grodin
Journal:  Heart Fail Rev       Date:  2021-01       Impact factor: 4.214

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.